Abstract: This invention relates generally to compositions and methods for treatment of pancreatic cancer. The present invention relates more particularly to use of JNK inhibition together with administration of TRAIL to selectively suppress cancer stem cells.
Type:
Grant
Filed:
July 29, 2015
Date of Patent:
June 25, 2019
Assignee:
Alliance of Cardiovascular Researches
Inventors:
Eckhard U Alt, Alejandro Recio Boiles, Matthias Ilmer
Abstract: Adult stem cells are reprogrammed to form pacemaker cells and Purkinje cells through the sequential activation of SHOX2>TBX5>HCN2. These Purkinje cells spontaneously surround and connect with the larger pacemaker cells, thus forming an induced sinoatrial body that produces funny current and can make cardiovascular tissues beat in a manner similar to a natural sinoatrial node.
Type:
Grant
Filed:
December 28, 2015
Date of Patent:
March 13, 2018
Assignees:
InGeneron Inc., Alliance of Cardiovascular Research